Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Carlos Guzmán

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Chemicals & Drugs

Procedures

Intranasal Administration

Physiology

Concepts & Ideas

Genes & Molecular Sequences

Amino Acid Sequence

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
18
Medina, Eva
14
Chhatwal, Gursharan
14
Ebensen, Thomas
13
Schulze, Kai
12
Becker, Pablo
11
Rohde, Manfred
11
Walker, Mark
10
Link, Claudia
8
Kresse, Andreas
6
Chakraborty, Trinad
6
Rharbaoui, Faiza
6
Talay, Susanne
5
Timmis, Kenneth
5
Staendner, Lothar
5
Pruzzo, Carla

Sign-in to see all Coauthors

Publications

TOP 3
Fiorentini Simona; Marsico Stefania; Becker Pablo D; Iaria Maria Luisa; Bruno Rosalinda; Guzmán Carlos A; Caruso Arnaldo
Synthetic peptide AT20 coupled to KLH elicits antibodies against a conserved conformational epitope from a major functional area of the HIV-1 matrix protein p17.
Vezzulli Luigi; Guzmán Carlos A; Colwell Rita R; Pruzzo Carla
Dual role colonization factors connecting Vibrio cholerae's lifestyles in human and aquatic environments open new perspectives for combating infectious diseases.
Cazorla Silvia I; Frank Fernanda M; Becker Pablo D; Corral Ricardo S; Guzmán Carlos A; Malchiodi Emilio L
Prime-boost immunization with cruzipain co-administered with MALP-2 triggers a protective immune response able to decrease parasite burden and tissue injury in an experimental Trypanosoma cruzi infection model.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Carlos Guzmán (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2008: Fiorentini Simona; Marsico Stefania; Becker Pablo D; Iaria Maria Luisa; Bruno Rosalinda; Guzmán Carlos A; Caruso Arnaldo
Synthetic peptide AT20 coupled to KLH elicits antibodies against a conserved conformational epitope from a major functional area of the HIV-1 matrix protein p17.
Vaccine 2008;26(36):4758-65.
2008: Vezzulli Luigi; Guzmán Carlos A; Colwell Rita R; Pruzzo Carla
Dual role colonization factors connecting Vibrio cholerae's lifestyles in human and aquatic environments open new perspectives for combating infectious diseases.
Current opinion in biotechnology 2008;19(3):254-9.
2008: Cazorla Silvia I; Frank Fernanda M; Becker Pablo D; Corral Ricardo S; Guzmán Carlos A; Malchiodi Emilio L
Prime-boost immunization with cruzipain co-administered with MALP-2 triggers a protective immune response able to decrease parasite burden and tissue injury in an experimental Trypanosoma cruzi infection model.
Vaccine 2008;26(16):1999-2009.
2008: Ebensen Thomas; Guzmán Carlos A
Immune modulators with defined molecular targets: cornerstone to optimize rational vaccine design.
Human vaccines 2008;4(1):13-22.
2008: Cazorla Silvia I; Becker Pablo D; Frank Fernanda M; Ebensen Thomas; Sartori María J; Corral Ricardo S; Malchiodi Emilio L; Guzmán Carlos A
Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi.
Infection and immunity 2008;76(1):324-33.
2008: Schulze Kai; Goldmann Oliver; Medina Eva; Guzmán Carlos A
The FAI protein of group C streptococci acts as a mucosal adjuvant by the specific targeting and activation of B cells.
International journal of medical microbiology : IJMM 2008;298(1-2):3-10.
2007: Royo José Luis; Becker Pablo Daniel; Camacho Eva María; Cebolla Angel; Link Claudia; Santero Eduardo; Guzmán Carlos Alberto
In vivo gene regulation in Salmonella spp. by a salicylate-dependent control circuit.
Nature methods 2007;4(11):937-42.
2007: Ebensen Thomas; Link Claudia; Riese Peggy; Schulze Kai; Morr Michael; Guzmán Carlos A
A pegylated derivative of alpha-galactosylceramide exhibits improved biological properties.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(4):2065-73.
2007: Ebensen Thomas; Schulze Kai; Riese Peggy; Morr Michael; Guzmán Carlos A
The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant.
Clinical and vaccine immunology : CVI 2007;14(8):952-8.
2007: Becker Pablo D; Nörder Miriam; Guzmán Carlos A; Grinstein Saul
Immune modulator adamantylamide dipeptide stimulates efficient major histocompatibility complex class I-restricted responses in mice.
Clinical and vaccine immunology : CVI 2007;14(5):538-43.
2007: Becker Pablo D; Bertot Gustavo M; Souss David; Ebensen Thomas; Guzmán Carlos A; Grinstein Saúl
Intranasal vaccination with recombinant outer membrane protein CD and adamantylamide dipeptide as the mucosal adjuvant enhances pulmonary clearance of Moraxella catarrhalis in an experimental murine model.
Infection and immunity 2007;75(4):1778-84.
2007: Ebensen Thomas; Schulze Kai; Riese Peggy; Link Claudia; Morr Michael; Guzmán Carlos A
The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties.
Vaccine 2007;25(8):1464-9.
2006: Schulze Kai; Olive Colleen; Ebensen Thomas; Guzmán Carlos A
Intranasal vaccination with SfbI or M protein-derived peptides conjugated to diphtheria toxoid confers protective immunity against a lethal challenge with Streptococcus pyogenes.
Vaccine 2006;24(35-36):6088-95.
2006: Link Claudia; Ebensen Thomas; Ständner Lothar; Déjosez Marion; Reinhard Elena; Rharbaoui Faiza; Guzmán Carlos A
An SopB-mediated immune escape mechanism of Salmonella enterica can be subverted to optimize the performance of live attenuated vaccine carrier strains.
Microbes and infection / Institut Pasteur 2006;8(8):2262-9.
2006: Gismondi María Inés; Becker Pablo Daniel; Valva Pamela; Guzmán Carlos Alberto; Preciado María Victoria
Phylogenetic analysis of previously nontypeable hepatitis C virus isolates from Argentina.
Journal of clinical microbiology 2006;44(6):2229-32.
2006: Becker Pablo D; Fiorentini Simona; Link Claudia; Tosti Giorgio; Ebensen Thomas; Caruso Arnaldo; Guzmán Carlos A
The HIV-1 matrix protein p17 can be efficiently delivered by intranasal route in mice using the TLR 2/6 agonist MALP-2 as mucosal adjuvant.
Vaccine 2006;24(25):5269-76.
2006: Borsutzky Stefan; Ebensen Thomas; Link Claudia; Becker Pablo Daniel; Fiorelli Valeria; Cafaro Aurelio; Ensoli Barbara; Guzmán Carlos A
Efficient systemic and mucosal responses against the HIV-1 Tat protein by prime/boost vaccination using the lipopeptide MALP-2 as adjuvant.
Vaccine 2006;24(12):2049-56.
2006: Schulze Kai; Medina Eva; Guzmán Carlos A
Intranasal immunization with serum opacity factor (SOF) of Streptococcus pyogenes fails to protect mice against lethal mucosal challenge with a heterologous strain.
Vaccine 2006;24(9):1446-50.
2005: Borsutzky Stefan; Kretschmer Karsten; Becker Pablo D; Mühlradt Peter F; Kirschning Carsten J; Weiss Siegfried; Guzmán Carlos A
The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(10):6308-13.
2005: Rharbaoui Faiza; Bruder Dunja; Vidakovic Melita; Ebensen Thomas; Buer Jan; Guzmán Carlos A
Characterization of a B220+ lymphoid cell subpopulation with immune modulatory functions in nasal-associated lymphoid tissues.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(3):1317-24.
2005: Schulze Kai; Goldmann Oliver; Toppel Antonia; Medina Eva; Guzmán Carlos A
The FAI protein of group C streptococci targets B-cells and exhibits adjuvant activity.
Vaccine 2005;23(11):1408-13.
2005: Guzmán Carlos A; Cebolla Angel; Beltrametti Fabricio; Staender Lothar H; de Lorenzo Víctor
Physiological stress of intracellular Shigella flexneri visualized with a metabolic sensor fused to a surface-reporter system.
FEBS letters 2005;579(3):813-8.
2004: Rharbaoui Faiza; Westendorf Astrid; Link Claudia; Felk Sandra; Buer Jan; Gunzer Matthias; Guzmán Carlos A
The Mycoplasma-derived macrophage-activating 2-kilodalton lipopeptide triggers global immune activation on nasal mucosa-associated lymphoid tissues.
Infection and immunity 2004;72(12):6978-86.
2004: Borsutzky Stefan; Cazac Balthazar B; Roes Jürgen; Guzmán Carlos A
TGF-beta receptor signaling is critical for mucosal IgA responses.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(5):3305-9.
2004: Fey Axel; Eichler Stefan; Flavier Sébastien; Christen Richard; Höfle Manfred G; Guzmán Carlos A
Establishment of a real-time PCR-based approach for accurate quantification of bacterial RNA targets in water, using Salmonella as a model organism.
Applied and environmental microbiology 2004;70(6):3618-23.
2004: Ebensen Thomas; Paukner Susanne; Link Claudia; Kudela Pavol; de Domenico Carola; Lubitz Werner; Guzmán Carlos A
Bacterial ghosts are an efficient delivery system for DNA vaccines.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(11):6858-65.
2004: McArthur J; Schulze K; Chin J; Currie B J; Sriprakash K S; Talay S R; Chhatwal G S; Guzmán C A; Walker M J
Immune responses of a liposome/ISCOM vaccine adjuvant against streptococcal fibronectin binding protein 1 (Sfb1) in mice.
The Indian journal of medical research 2004;119 Suppl():115-20.
2004: Bertot Gustavo M; Becker Pablo D; Guzmán Carlos A; Grinstein Saúl
Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae.
The Journal of infectious diseases 2004;189(7):1304-12.
2004: Gismondi María Inés; Staendner Lothar Heinrich; Grinstein Saúl; Guzmán Carlos Alberto; Preciado María Victoria
Hepatitis C virus isolates from Argentina disclose a novel genotype 1-associated restriction pattern.
Journal of clinical microbiology 2004;42(3):1298-301.
2004: Link Claudia; Gavioli Riccardo; Ebensen Thomas; Canella Alessandro; Reinhard Elena; Guzmán Carlos A
The Toll-like receptor ligand MALP-2 stimulates dendritic cell maturation and modulates proteasome composition and activity.
European journal of immunology 2004;34(3):899-907.
2003: Schulze Kai; Medina Eva; Chhatwal Gursharan S; Guzmán Carlos A
Identification of B- and T-cell epitopes within the fibronectin-binding domain of the SfbI protein of Streptococcus pyogenes.
Infection and immunity 2003;71(12):7197-201.
2003: Buttò Stefano; Fiorelli Valeria; Tripiciano Antonella; Ruiz-Alvarez Maria J; Scoglio Arianna; Ensoli Fabrizio; Ciccozzi Massimo; Collacchi Barbara; Sabbatucci Michela; Cafaro Aurelio; Guzmán Carlos A; Borsetti Alessandra; Caputo Antonella; Vardas Eftyhia; Colvin Mark; Lukwiya Matthew; Rezza Giovanni; Ensoli Barbara;
Sequence conservation and antibody cross-recognition of clade B human immunodeficiency virus (HIV) type 1 Tat protein in HIV-1-infected Italians, Ugandans, and South Africans.
The Journal of infectious diseases 2003;188(8):1171-80.
2003: Schulze Kai; Guzmán Carlos A
Identification of the domains of the fibronectin-binding protein I of Streptococcus pyogenes responsible for adjuvanticity.
FEMS immunology and medical microbiology 2003;37(2-3):173-7.
2003: Borsutzky Stefan; Fiorelli Valeria; Ebensen Thomas; Tripiciano Antonella; Rharbaoui Faiza; Scoglio Arianna; Link Claudia; Nappi Filomena; Morr Michael; Buttó Stefano; Cafaro Aurelio; Mühlradt Peter F; Ensoli Barbara; Guzmán Carlos A
Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvant.
European journal of immunology 2003;33(6):1548-56.
2003: Schulze Kai; Medina Eva; Chhatwal Gursharan S; Guzmán Carlos A
Stimulation of long-lasting protection against Streptococcus pyogenes after intranasal vaccination with non adjuvanted fibronectin-binding domain of the SfbI protein.
Vaccine 2003;21(17-18):1958-64.
2003: McArthur Jason D; West Nicholas P; Cole Jason N; Jungnitz Heidrun; Guzmán Carlos A; Chin James; Lehrbach Philip R; Djordjevic Steven P; Walker Mark J
An aromatic amino acid auxotrophic mutant of Bordetella bronchiseptica is attenuated and immunogenic in a mouse model of infection.
FEMS microbiology letters 2003;221(1):7-16.
2002: Rharbaoui Faiza; Drabner Birgit; Borsutzky Stefan; Winckler Urte; Morr Michael; Ensoli Barbara; Mühlradt Peter F; Guzmán Carlos A
The Mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvant.
European journal of immunology 2002;32(10):2857-65.
2002: Basso Holger; Rharbaoui Faiza; Staendner Lothar H; Medina Eva; García-Del Portillo Francisco; Guzmán Carlos A
Characterization of a novel intracellularly activated gene from Salmonella enterica serovar typhi.
Infection and immunity 2002;70(10):5404-11.
2002: Erdogan Sezgin; Fagan Peter K; Talay Susanne R; Rohde Manfred; Ferrieri Patricia; Flores Aurea E; Guzmán Carlos A; Walker Mark J; Chhatwal Gursharan S
Molecular analysis of group B protective surface protein, a new cell surface protective antigen of group B streptococci.
Infection and immunity 2002;70(2):803-11.
2001: Kresse A U; Guzmán C A; Ebel F
Modulation of host cell signalling by enteropathogenic and Shiga toxin-producing Escherichia coli.
International journal of medical microbiology : IJMM 2001;291(4):277-85.
2001: Becker P D; Corral R S; Guzmán C A; Grinstein S
Adamantylamide dipeptide as effective immunoadjuvant in rabbits and mice.
Vaccine 2001;19(32):4603-9.
2001: Zimna K; Medina E; Jungnitz H; Guzmán C A
Role played by the response regulator Ris in Bordetella bronchiseptica resistance to macrophage killing.
FEMS microbiology letters 2001;201(2):177-80.
2001: Smith A M; Guzmán C A; Walker M J
The virulence factors of Bordetella pertussis: a matter of control.
FEMS microbiology reviews 2001;25(3):309-33.
2001: Drabner B; Guzmán C A
Elicitation of predictable immune responses by using live bacterial vectors.
Biomolecular engineering 2001;17(3):75-82.
2001: Medina E; Guzmán C A
Use of live bacterial vaccine vectors for antigen delivery: potential and limitations.
Vaccine 2001;19(13-14):1573-80.
2001: Schulze K; Medina E; Talay S R; Towers R J; Chhatwal G S; Guzmán C A
Characterization of the domain of fibronectin-binding protein I of Streptococcus pyogenes responsible for elicitation of a protective immune response.
Infection and immunity 2001;69(1):622-5.
2000: Kresse A U; Beltrametti F; Müller A; Ebel F; Guzmán C A
Characterization of SepL of enterohemorrhagic Escherichia coli.
Journal of bacteriology 2000;182(22):6490-8.
2000: Medina E; Schulze K; Chhatwal G S; Guzmán C A
Nonimmune interaction of the SfbI protein of Streptococcus pyogenes with the immunoglobulin G F(ab')(2) fragment.
Infection and immunity 2000;68(8):4786-8.
2000: West N P; Jungnitz H; Fitter J T; McArthur J D; Guzmán C A; Walker M J
Role of phosphoglucomutase of Bordetella bronchiseptica in lipopolysaccharide biosynthesis and virulence.
Infection and immunity 2000;68(8):4673-80.
2000: García-Del Portillo F; Jungnitz H; Rohde M; Guzmán C A
Interaction of Salmonella enterica serotype Typhimurium with dendritic cells is defined by targeting to compartments lacking lysosomal membrane glycoproteins.
Infection and immunity 2000;68(5):2985-91.
2000: Molinari G; Rohde M; Guzmán C A; Chhatwal G S
Two distinct pathways for the invasion of Streptococcus pyogenes in non-phagocytic cells.
Cellular microbiology 2000;2(2):145-54.
2000: Medina E; Guzmán C A
Modulation of immune responses following antigen administration by mucosal route.
FEMS immunology and medical microbiology 2000;27(4):305-11.
2000: Medina E; Paglia P; Rohde M; Colombo M P; Guzmán C A
Modulation of host immune responses stimulated by Salmonella vaccine carrier strains by using different promoters to drive the expression of the recombinant antigen.
European journal of immunology 2000;30(3):768-77.
2000: Beltrametti F; Kresse A U; Guzmán C A
Transcriptional regulation of the pas gene of enterohemorrhagic Escherichia coli.
FEMS microbiology letters 2000;184(1):119-25.
2000: Basso H; Rohde M; Guzmán C A
Vectors to achieve selective expression of vaccine antigens within eukaryotic cells using Salmonella spp. as carrier strains.
FEMS microbiology letters 2000;182(2):219-23.
1999: McMillan D J; Medina E; Guzmán C A; Walker M J
Expression of urease does not affect the ability of Bordetella bronchiseptica to colonise and persist in the murine respiratory tract.
FEMS microbiology letters 1999;178(1):7-11.
1999: Medina E; Molinari G; Rohde M; Haase B; Chhatwal G S; Guzmán C A
Fc-mediated nonspecific binding between fibronectin-binding protein I of Streptococcus pyogenes and human immunoglobulins.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(6):3396-402.
1999: Kresse A U; Rohde M; Guzmán C A
The EspD protein of enterohemorrhagic Escherichia coli is required for the formation of bacterial surface appendages and is incorporated in the cytoplasmic membranes of target cells.
Infection and immunity 1999;67(9):4834-42.
1999: Beltrametti F; Kresse A U; Guzmán C A
Transcriptional regulation of the esp genes of enterohemorrhagic Escherichia coli.
Journal of bacteriology 1999;181(11):3409-18.
1999: Guzmán C A; Talay S R; Molinari G; Medina E; Chhatwal G S
Protective immune response against Streptococcus pyogenes in mice after intranasal vaccination with the fibronectin-binding protein SfbI.
The Journal of infectious diseases 1999;179(4):901-6.
1999: Medina E; Paglia P; Nikolaus T; Müller A; Hensel M; Guzmán C A
Pathogenicity island 2 mutants of Salmonella typhimurium are efficient carriers for heterologous antigens and enable modulation of immune responses.
Infection and immunity 1999;67(3):1093-9.
1999: Medina E; Guzmán C A; Staendner L H; Colombo M P; Paglia P
Salmonella vaccine carrier strains: effective delivery system to trigger anti-tumor immunity by oral route.
European journal of immunology 1999;29(2):693-9.
1998: Medina E; Talay S R; Chhatwal G S; Guzmán C A
Fibronectin-binding protein I of Streptococcus pyogenes promotes T cell-independent proliferation of murine B lymphocytes and enhances the expression of MHC class II molecules on antigen-presenting cells.
International immunology 1998;10(11):1657-64.
1998: Ebel F; Podzadel T; Rohde M; Kresse A U; Krämer S; Deibel C; Guzmán C A; Chakraborty T
Initial binding of Shiga toxin-producing Escherichia coli to host cells and subsequent induction of actin rearrangements depend on filamentous EspA-containing surface appendages.
Molecular microbiology 1998;30(1):147-61.
1998: Jungnitz H; West N P; Walker M J; Chhatwal G S; Guzmán C A
A second two-component regulatory system of Bordetella bronchiseptica required for bacterial resistance to oxidative stress, production of acid phosphatase, and in vivo persistence.
Infection and immunity 1998;66(10):4640-50.
1998: Kresse A U; Schulze K; Deibel C; Ebel F; Rohde M; Chakraborty T; Guzmán C A
Pas, a novel protein required for protein secretion and attaching and effacing activities of enterohemorrhagic Escherichia coli.
Journal of bacteriology 1998;180(17):4370-9.
1998: Guzmán C A; Saverino D; Medina E; Fenoglio D; Gerstel B; Merlo A; Li Pira G; Buffa F; Chakraborty T; Manca F
Attenuated Listeria monocytogenes carrier strains can deliver an HIV-1 gp120 T helper epitope to MHC class II-restricted human CD4+ T cells.
European journal of immunology 1998;28(6):1807-14.
1998: Medina E; Talay S R; Chhatwal G S; Guzmán C A
Fibronectin-binding protein I of Streptococcus pyogenes is a promising adjuvant for antigens delivered by mucosal route.
European journal of immunology 1998;28(3):1069-77.
1998: Dalla Pozza T; Yan H; Meek D; Guzmán C A; Walker M J
Construction and characterisation of Salmonella typhimurium aroA simultaneously expressing the five pertussis toxin subunits.
Vaccine 1998;16(5):522-9.
1997: Darji A; Guzmán C A; Gerstel B; Wachholz P; Timmis K N; Wehland J; Chakraborty T; Weiss S
Oral somatic transgene vaccination using attenuated S. typhimurium.
Cell 1997;91(6):765-75.
1997: Suarez A; Güttler A; Strätz M; Staendner L H; Timmis K N; Guzmán C A
Green fluorescent protein-based reporter systems for genetic analysis of bacteria including monocopy applications.
Gene 1997;196(1-2):69-74.
1997: Klee S R; Tzschaschel B D; Singh M; Fält I; Lindberg A A; Timmis K N; Guzmán C A
Construction and characterization of genetically-marked bivalent anti-Shigella dysenteriae 1 and anti-Shigella flexneri Y live vaccine candidates.
Microbial pathogenesis 1997;22(6):363-76.
1997: Klee S R; Tzschaschel B D; Fält I; Kärnell A; Lindberg A A; Timmis K N; Guzmán C A
Construction and characterization of a live attenuated vaccine candidate against Shigella dysenteriae type 1.
Infection and immunity 1997;65(6):2112-8.
1997: Chhatwal G S; Walker M J; Yan H; Timmis K N; Guzmán C A
Temperature dependent expression of an acid phosphatase by Bordetella bronchiseptica: role in intracellular survival.
Microbial pathogenesis 1997;22(5):257-64.
1997: West N P; Fitter J T; Jakubzik U; Rohde M; Guzmán C A; Walker M J
Non-motile mini-transposon mutants of Bordetella bronchiseptica exhibit altered abilities to invade and survive in eukaryotic cells.
FEMS microbiology letters 1997;146(2):263-9.
1997: Suarez A; Staendner L H; Rohde M; Piatti G; Timmis K N; Guzmán C A
Stable expression of pertussis toxin in Bordetella bronchiseptica under the control of a tightly regulated promoter.
Applied and environmental microbiology 1997;63(1):122-7.
1996: McMillan D J; Shojaei M; Chhatwal G S; Guzmán C A; Walker M J
Molecular analysis of the bvg-repressed urease of Bordetella bronchiseptica.
Microbial pathogenesis 1996;21(5):379-94.
1996: Ebel F; Deibel C; Kresse A U; Guzmán C A; Chakraborty T
Temperature- and medium-dependent secretion of proteins by Shiga toxin-producing Escherichia coli.
Infection and immunity 1996;64(11):4472-9.
1996: Tzschaschel B D; Klee S R; de Lorenzo V; Timmis K N; Guzmán C A
Towards a vaccine candidate against Shigella dysenteriae 1: expression of the Shiga toxin B-subunit in an attenuated Shigella flexneri aroD carrier strain.
Microbial pathogenesis 1996;21(4):277-88.
1996: Tzschaschel B D; Guzmán C A; Timmis K N; de Lorenzo V
An Escherichia coli hemolysin transport system-based vector for the export of polypeptides: export of Shiga-like toxin IIeB subunit by Salmonella typhimurium aroA.
Nature biotechnology 1996;14(6):765-9.
1996: Guzmán C A; Domann E; Rohde M; Bruder D; Darji A; Weiss S; Wehland J; Chakraborty T; Timmis K N
Apoptosis of mouse dendritic cells is triggered by listeriolysin, the major virulence determinant of Listeria monocytogenes.
Molecular microbiology 1996;20(1):119-26.
1996: Molinari G; Pugliese V; Schito G C; Guzmán C A
Bacteria involved in the blockage of biliary stents and their susceptibility to antibacterial agents.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1996;15(1):88-92.
1995: Staendner L H; Rohde M; Timmis K N; Guzmán C A
Identification of Salmonella typhi promoters activated by invasion of eukaryotic cells.
Molecular microbiology 1995;18(5):891-902.
1994: Guzmán C A; Piatti G; Walker M J; Guardati M C; Pruzzo C
A novel Escherichia coli expression-export vector containing alkaline phosphatase as an insertional inactivation screening system.
Gene 1994;148(1):171-2.
1993: Molinari G; Guzmán C A; Pesce A; Schito G C
Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics.
The Journal of antimicrobial chemotherapy 1993;31(5):681-8.
1990: Guzmán C A; Platé M; Pruzzo C
Role of neuraminidase-dependent adherence in Bacteroides fragilis attachment to human epithelial cells.
FEMS microbiology letters 1990;59(1-2):187-92.
1989: Pruzzo C; Guzmán C A; Dainelli B
Incidence of hemagglutination activity among pathogenic and non-pathogenic Bacteroides fragilis strains and role of capsule and pili in HA and adherence.
FEMS microbiology letters 1989;50(1-2):113-8.
1989: Pruzzo C; Guzmán C A; Calegari L; Satta G
Impairment of phagocytosis by the Klebsiella pneumoniae mannose-inhibitable adhesin-T7 receptor.
Infection and immunity 1989;57(3):975-82.

Sign-in to see more